(Q51839766)

13 April 2018

title

Vecuronium in renal failure (English)

1 reference

Anesthesiology and pain medicine

15 August 2023

main subject

1 reference

15 August 2023

author name string

D. R. Bevan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6149801

15 August 2023

F. Donati

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6149801

15 August 2023

H. Gyasi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6149801

15 August 2023

A. Williams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6149801

15 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6149801

15 August 2023

publication date

1 September 1984

1 reference

13 April 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF03009532.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF03009532/fulltext.html

15 August 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF03009532

15 August 2023

1 reference

Canadian Anaesthetists' Society journal

15 August 2023

published in

1 reference

13 April 2018

volume

31

1 reference

13 April 2018

issue

5

1 reference

13 April 2018

page(s)

491-496

1 reference

13 April 2018

Gallamine disposition in surgical patients with chronic renal failure

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03009532

Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat

21 January 2018

1 reference

12 December 2020

The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide

1 reference

12 December 2020

Use of atracurium in patients with no renal function

1 reference

12 December 2020

Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure

1 reference

12 December 2020

The pharmacokinetics of d-tubocurarine in man with and without renal failure

1 reference

12 December 2020

Renal failure and postoperative respiratory failure: recurarization?

1 reference

12 December 2020

Antagonism of pancuronium in renal failure: no recurarization.

1 reference

12 December 2020

The emergence of ORG NC 45, 1- [2 beta,3 alpha,5 alpha,16 beta,17 beta)-3, 17-bis(acetyloxy)-2-(1-piperidinyl)-androstan-16-yl]-1-methylpiperidinium bromide, from the pancuronium series

1 reference

12 December 2020

Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.

1 reference

12 December 2020

Stimulus frequency in the detection of neuromuscular block in humans.

1 reference

12 December 2020

Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man

1 reference

12 December 2020

A simplified method of evaluating dose-effect experiments

1 reference

12 December 2020

Renal and biliary elimination of vecuronium (ORG NC 45) and pancuronium in rats

1 reference

12 December 2020

Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.

1 reference

12 December 2020

Dose-response relation for atracurium, ORG NC 45 and pancuronium

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03009532

1 reference

13 April 2018

1 reference

13 April 2018